Compounds > tbc-11251
Page last updated: 2024-09-05

tbc-11251 and Lung Diseases, Obstructive

tbc-11251 has been researched along with Lung Diseases, Obstructive in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wu-Wong, JR1

Reviews

1 review(s) available for tbc-11251 and Lung Diseases, Obstructive

ArticleYear
Sitaxsentan (ICOS-Texas Biotechnology).
    Current opinion in investigational drugs (London, England : 2000), 2001, Volume: 2, Issue:4

    Topics: Animals; Clinical Trials as Topic; Endothelin Receptor Antagonists; Heart Failure; Humans; Isoxazoles; Lung Diseases, Obstructive; Receptor, Endothelin A; Subarachnoid Hemorrhage; Thiophenes

2001